In summary, we evaluated the therapeutic potential of the anti-TM4SF5 chimeric antibody Ab27 using liver and colon cancer cells expressing TM4SF5 in vitro and in vivo. This evidence concerns the gene TM4SF5 and malignant colon neoplasm.